author-photo

Varvara Polydoropoulou

National and Kapodistrian University of Athens

10

Papers

201

Citations

Citation Trend

Filter By

Papers (10) Sort By

JournalConferenceOthers

LBA91_PRA multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM): Results from the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (68)
A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project

2019 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (20)
Efficacy of Adoptive Therapy with Tumor-infiltrating Lymphocytes and Recombinant Interleukin-2 in Advanced Cutaneous Melanoma: A Systematic Review and Meta-analysis

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (54)
Exploratory Analysis of Single-Gene Predictive Biomarkers in HERA DASL Cohort Reveals That C8A mRNA Expression Is Prognostic of Outcome and Predictive of Benefit of Trastuzumab

2018
Show All
- Source
- Cite
- Save
Citations (1)
Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study

2018 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (10)
Prevalence and clinical correlation of programmed cell death 1 ligand (PD-L1) expression in patients with resected non-small cell lung cancer (NSCLC): Results from the European Thoracic Oncology Platform (ETOP) Lungscape cohort.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
1630PDAssociation of programmed cell death 1 ligand (PD-L1) expression with molecular alterations in non-small cell lung cancer (NSCLC) patients (pts): Results from the European Thoracic Oncology Platform (ETOP) Lungscape cohort

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab: A Secondary Analysis of the HERA Trial

2016 JAMA Oncology
Show All
- Source
- Cite
- Save
Citations (47)
Abstract P5-18-01: TransHERA: The cell cycle regulator p27 predicts benefit from trastuzumab treatment in HER2-positive early breast cancer patients treated within the HERA trial

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P3-06-02: Exploratory analysis of single gene predictive biomarkers in TransHERA DASL cohort reveals that C8A mRNA expression is prognostic of outcome and predictive of benefit of trastuzumab

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号